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Abstract
Lung cancer remains one of the deadliest types of cancer, causing approximately 160,000 deaths per year
in the US alone. Because of its poor detection techniques and highly invasive abilities, conventional
treatments -such as radiation and chemotherapy- fail to improve long-term survival of patients. At the
moment, the 5-year survival rate for all stages of lung cancer is only 16%. Recent breakthroughs in cancer
research establish immunotherapy, which involves the stimulation of the immune system to target and
attack cancer cells, as a highly promising alternative treatment against this deadly disease. However, the
efficiency of this treatment varies on each subset of cancer. A more efficient therapeutic strategy should
include the targeting of immunosuppressive factors along with key proteins that are responsible for lung
tumor growth. A possible target is the Retinoblastoma protein (Rb). This well-known tumor suppressor
regulates a diverse set of cellular processes such as cell cycle progression and cell adhesion. Inactivation
of Rb results in uncontrolled cell proliferation, which is a major driving force behind tumorigenesis. Recent
findings suggest a new role for Rb in regulating immune system function. To further characterize this
emerging role of Rb in immune function, the protein expression of PD-L1, PD1, OX-40, OX40L, B7-H3 and
B7-H4 was analyzed via immunoblotting in Rb-activated and Rb-inactivated lung cancer cell lines. Our
hypothesis is that Rb will affect the expression of these immunosuppressive factors in tumor cells.
Preliminary results show that PD-L1 and OX-40 expression is correlated to Rb active status, while PD1 and
OX40L are expressed when Rb is inactivated.
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ABSTRACT
Lung cancer remains one of the deadliest types of cancer, causing approximately 160,000
deaths per year in the US alone. Because of its poor detection techniques and highly invasive
abilities, conventional treatments -such as radiation and chemotherapy- fail to improve long-term
survival of patients. At the moment, the 5-year survival rate for all stages of lung cancer is only
16%. Recent breakthroughs in cancer research establish immunotherapy, which involves the
stimulation of the immune system to target and attack cancer cells, as a highly promising
alternative treatment against this deadly disease. However, the efficiency of this treatment varies
on each subset of cancer. A more efficient therapeutic strategy should include the targeting of
immunosuppressive factors along with key proteins that are responsible for lung tumor growth.
A possible target is the Retinoblastoma protein (Rb). This well-known tumor suppressor
regulates a diverse set of cellular processes such as cell cycle progression and cell adhesion.
Inactivation of Rb results in uncontrolled cell proliferation, which is a major driving force behind
tumorigenesis. Recent findings suggest a new role for Rb in regulating immune system function.
To further characterize this emerging role of Rb in immune function, the protein expression of
PD-L1, PD1, OX-40, OX40L, B7-H3 and B7-H4 was analyzed via immunoblotting in Rbactivated and Rb-inactivated lung cancer cell lines. Our hypothesis is that Rb will affect the
expression of these immunosuppressive factors in tumor cells. Preliminary results show that PDL1 and OX-40 expression is correlated to Rb active status, while PD1 and OX40L are expressed
when Rb is inactivated.
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